BOL Pharma has been pioneering the creation of the medical cannabis industry in Israel since 2008. Working in conjunction with the Israeli Ministry of Health and under governmental licenses, BOL serves thousands of patients, doctors, HMOs, and hospitals providing cannabis based medical products and cannabinoid APIs (active pharmaceutical ingredients) as a full service CDMO for clinical research, pharmaceuticals, food supplements and dermacosmetics.
BOL Pharma is a CDMO that offers expertise in both early-stage API clinical development and commercial supply. The company provides one-stop-shop services for formulation development and manufacturing throughout the lifecycle of drug development ensuring supply chain quality control coupled with complete production flexibility. Years of combining high-tech innovation with extensive agriculture know how have contributed to the development of precise agro-methodologies enabling the complete control of the growth environment. Plants are grown and cultivated in controlled conditions, at the highest of standards, while fully managing the plants chemical profile. A unique and proprietary combination of monitoring and control methods have enabled BOL to produce highly consistent botanical based products with end-products that deliver maximized medical value. BOL farms operate in complete compliance with GAP/GMP international standards
BOL is engaged in collaborations with universities, academic institutions, and hospitals to develop novel drugs and obtain regulatory approvals in these therapeutic areas:
- Immunology (Multiple Sclerosis, Fibromyalgia)
- Pain Management (Chronic Pain, Neuropathic Pain)
- Gastrointestinal Diseases (IBD)
- Rheumatology (Osteoarthritis)
- Dermatology (Psoriasis, Atopic Dermatitis)
BOL Pharma is led by a seasoned team of medical experts, researchers, and business professionals bringing a wealth of experience and expertise in clinical research, precision agriculture, production and marketing of pharma and health products.